D

Duopharma Biotech Bhd
KLSE:DPHARMA

Watchlist Manager
Duopharma Biotech Bhd
KLSE:DPHARMA
Watchlist
Price: 1.23 MYR
Market Cap: 1.2B MYR
Have any thoughts about
Duopharma Biotech Bhd?
Write Note

Duopharma Biotech Bhd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Duopharma Biotech Bhd
Gross Profit Peer Comparison

Comparables:
P
PLABS
A
AHEALTH
R
RHONEMA
Y
YSPSAH
K
KOTRA

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
D
Duopharma Biotech Bhd
KLSE:DPHARMA
Gross Profit
myr269.2m
CAGR 3-Years
4%
CAGR 5-Years
4%
CAGR 10-Years
14%
P
PeterLabs Holdings Bhd
KLSE:PLABS
Gross Profit
myr22.8m
CAGR 3-Years
4%
CAGR 5-Years
5%
CAGR 10-Years
8%
A
Apex Healthcare Bhd
KLSE:AHEALTH
Gross Profit
myr218.9m
CAGR 3-Years
16%
CAGR 5-Years
8%
CAGR 10-Years
7%
R
Rhone Ma Holdings Bhd
KLSE:RHONEMA
Gross Profit
myr55m
CAGR 3-Years
7%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Y
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
Gross Profit
myr161.2m
CAGR 3-Years
12%
CAGR 5-Years
4%
CAGR 10-Years
6%
K
Kotra Industries Bhd
KLSE:KOTRA
Gross Profit
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Duopharma Biotech Bhd's Gross Profit?
Gross Profit
269.2m MYR

Based on the financial report for Jun 30, 2024, Duopharma Biotech Bhd's Gross Profit amounts to 269.2m MYR.

What is Duopharma Biotech Bhd's Gross Profit growth rate?
Gross Profit CAGR 10Y
14%

Over the last year, the Gross Profit growth was -5%. The average annual Gross Profit growth rates for Duopharma Biotech Bhd have been 4% over the past three years , 4% over the past five years , and 14% over the past ten years .

Back to Top